Anti-NOXA2/p67phox antibody [EPR5064]
- RabMAb
- Recombinant
- What is this?
4
(3 Reviews)
|
(22 Publications)
Rabbit Recombinant Monoclonal NOXA2/p67phox antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 22 publications.
View Alternative Names
NOXA2, P67PHOX, NCF2, Neutrophil cytosol factor 2, NCF-2, 67 kDa neutrophil oxidase factor, NADPH oxidase activator 2, Neutrophil NADPH oxidase factor 2, p67-phox
- WB
Unknown
Western blot - Anti-NOXA2/p67phox antibody [EPR5064] (AB109366)
All lanes:
Western blot - Anti-NOXA2/p67phox antibody [EPR5064] (ab109366) at 1/1000 dilution
Lane 1:
HL-60 cells treated with dexomethasome, dimethyl sulfoxide, and TPA at 10 µg
Lane 2:
THP-1 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-Rabbit at 1/2000 dilution
Predicted band size: 60 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NOXA2/p67phox antibody [EPR5064] (AB109366)
Immunohistochemical analysis of NOXA2/p67phox in paraffin-embedded Human spleen tissue using ab109366 at 1/500 dilution
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Related conjugates and formulations (3)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-NOXA2/p67phox antibody [EPR5064]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-NOXA2/p67phox antibody [EPR5064]
-
Anti-NOXA2/p67phox antibody [EPR5064] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NOXA2 contributes to superoxide production by facilitating electron transfer in the NADPH oxidase complex. This complex is integral to the immune system's ability to target and destroy infectious agents. NOXA2/p67phox forms a complex with other components such as gp91phox and p22phox which are required for full activation of the oxidase. The coordinated action of these complexes ensures effective ROS production which is a vital component of the defense mechanism of immune cells.
Pathways
NOXA2 participates in the respiratory burst pathway an important element of innate immunity. This pathway involves the conversion of oxygen to superoxide a process requiring precise interaction with cytochrome b558 and the Rac protein. NOXA2 is also related to signal transduction pathways including those modulated by protein kinase C which further regulates its activation during the immune response. The orchestration of these pathways allows for an effective immune defense mechanism.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Phytotherapy research : PTR 38:5441-5457 PubMed39289784
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:6218 PubMed39043696
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:5170 PubMed38886341
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of radiation research 65:291-302 PubMed38588586
2024
Applications
Unspecified application
Species
Unspecified reactive species
Renal failure 45:2199095 PubMed37038746
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 12:8991-9004 PubMed36680322
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:800522 PubMed35002735
2021
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 30:101432 PubMed31986467
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pharmacology and experimental thera 371:348-359 PubMed31467086
2019
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 15:e1008004 PubMed31412082
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com